Steve Silvestro & OptimizeRx

Steve Silvestro: Steve Silvestro, CEO of OptimizeRx, emphasized the importance of DSPs as a growth channel for OptimizeRx and the value NLAB brings to partners and clients.

OptimizeRx: OptimizeRx launched its patent-pending Natural Language Audience Builder (NLAB), an AI-powered tool, which is expected to create new recurring revenue streams and expand its role as an infrastructure partner in the life sciences industry.

Steve Silvestro: Steve Silvestro, CEO of OptimizeRx, emphasized CopayCue's alignment with the company's commitment to improving life sciences marketing and expanding patient access to therapy.

OptimizeRx: OptimizeRx launched CopayCue, a new solution designed to enhance brand savings offers within the e-prescribing workflow, which is expected to improve its market position and revenue.

Steve Silvestro: Steve Silvestro, CEO of OptimizeRx, commented on the appointment of Mary Varghese Presti, highlighting her experience as aligning with the company's strategy.

OptimizeRx: OptimizeRx appointed Mary Varghese Presti to its Board of Directors, which is expected to help accelerate growth, expand its product portfolio, and deliver long-term shareholder value.